Keywords: Spectroscopy, Brain, Metabolism, Hepatic Encephalopathy, proton
Type C hepatic encephalopathy (HE) is a severe neuropsychiatric disorder associated with chronic liver disease. Ammonia (partially produced in the gut by bacterial urease activity) has been pinpointed to explain the observed neurological alterations in HE and connected with the increase in brain Gln measured using 1H-MRS. As such current treatment strategies focus on either reducing ammonia production and absorption or on promoting its elimination. We showed that targeting urease activity using the urease inhibitor 2-octynoHA has a beneficial effect in reducing blood ammonia levels and reducing brain Gln measured using 1H-MRS at 9.4T in the cerebellum.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords